-
Most Popular
![Biotech Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/biotech-150x150.png)
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Biochemical/biotech research scientist team working with microscope](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715-150x150.png)
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
![Nurse holding a tablet with icons representing different aspects of healthcare and healthcare data representing CANO stock. Healthcare Tech Stocks. Healthcare Stocks to Buy](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600-150x150.jpg)
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
T2 Biosystems Preps to Resell 141 Million Shares of TTOO Stock
TTOO stock is in the red after the company filed for the resale of up to 141.64 million shares for CR Group L.P.
GILD Stock Alert: FDA Expands Indications for Gilead Sciences’ Veklury Covid-19 Treatment
Gilead Sciences (GILD) stock is on the move Thursday following additional FDA approval for its Veklury Covid-19 treatment.
Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock
Cassava is still enrolling patients in its Phase 3 study of the drug, which has a different target than Biogen's Leqembi.
MNK Stock Alert: Mallinckrodt Files for Bankruptcy Again
Mallinckrodt (MNK) stock isn't doing so hot on Wednesday after the pharmaceutical company gets ready for another bankruptcy filing.
Why Is Kiora Pharmaceuticals (KPRX) Stock Up 11% Today?
Kiora Pharmaceuticals (KPRX) stock is getting a boost on Wednesday after the company revealed new patents in the U.S. and Europe.
Why Is Apellis Pharmaceuticals (APLS) Stock Up 23% Today?
Apellis Pharmaceuticals (APLS) stock is on the rise Wednesday after the biopharmaceutical company announced an update on injection kits.
Why Is Fulcrum Therapeutics (FULC) Stock Up 43% Today?
Fulcrum Therapeutics (FULC) stock is on the rise Tuesday after the FDA removed a clinical hold on its sickle-cell disease candidate.
Novavax (NVAX) Stock Is Getting Ready to Rally Again
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot.
Why Is Axcella Health (AXLA) Stock Up 68% Today?
Axcella Health (AXLA) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biotechnology company.
Why Is Novavax (NVAX) Stock Up 15% Today?
Investors in Novavax have had a very rough go over the past two years, but NVAX stock is rebounding nicely today.
TTOO Stock Alert: T2 Biosystems Seeks Approval for Reverse Stock Split
TTOO stock investors are anticipating T2's annual meeting next month. Up for vote is a reverse stock split.
Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today?
Timber Pharmaceuticals (TMBR) stock is undergoing a rally on Monday after announcing that Leo US is acquiring it in a $36 million deal.
Why Is China SXT Pharmaceuticals (SXTC) Stock Up 110% Today?
China SXT Pharmaceuticals (SXTC) stock is rocketing higher on Monday despite a lack of news from the pharmaceutical company.
Why Is Aditxt (ADTX) Stock Up 10% Today?
Although Aditxt delivered a key shareholder update that boosted sentiment, ADTX stock remains a speculative venture.